| Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q3 24 |
|---|---|---|---|---|---|---|
| End date of the reporting period | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Capitalization, $ | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Capitalization, $ | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Enterprise Value | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Book Value | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Shareholders Book Value | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Current liabilities | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Noncurrent liabilities | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Total liabilities | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Debt | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Cash and cash equivalents | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Net debt | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Assets | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Total ordinary shares | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Ordinary share price | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
ml.globenewswire.com
sterisplc.gcs-web.com
ml.globenewswire.com
sterisplc.gcs-web.com| Company name | Steris |
|---|---|
| Tags | #s&p500 index |
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies |
| Business address | 70 SIR JOHN ROGERSON'S QUAY DUBLIN L2 2 35312322000 |
| Mailing address | 70 SIR JOHN ROGERSON'S QUAY DUBLIN L2 2 |
| Website | sterisplc.gcs-web.com |
| Information disclosure | www.sec.gov |